Weitz JI. Arterial thrombosis: present and future. Circulation. 2024;150(12):905–7. https://doi.org/10.1161/circulationaha.124.070541.

Article  PubMed  Google Scholar 

Kawai K, Kawakami R, Finn AV, Virmani R. Differences in stable and unstable atherosclerotic plaque. Arterioscler Thromb Vasc Biol. 2024;44(7):1474–84. https://doi.org/10.1161/atvbaha.124.319396.

Article  CAS  PubMed  Google Scholar 

Cesaro A, Acerbo V, Indolfi C, Filardi PP, Calabrò P. The clinical relevance of the reversal of coronary atherosclerotic plaque. Eur J Intern Med. 2024;129:16–24. https://doi.org/10.1016/j.ejim.2024.08.010.

Article  CAS  PubMed  Google Scholar 

Bruoha S, Galli M, Sabouret P, et al. Atherosclerotic plaque erosion: mechanisms, clinical implications, and potential therapeutic strategies-a review. J Cardiovasc Pharmacol. 2024;83(6):547–56. https://doi.org/10.1097/fjc.0000000000001554.

Article  CAS  PubMed  Google Scholar 

Meng H, Ruan J, Yan Z, et al. New progress in early diagnosis of atherosclerosis. Int J Mol Sci. 2022. https://doi.org/10.3390/ijms23168939.

Article  PubMed Central  PubMed  Google Scholar 

Xiong M, Zhang Z, Cui J, Du X, Chen Y, Zhang T. Dengyinnaotong attenuates atherosclerotic lesions, gut dysbiosis and intestinal epithelial barrier impairment in the high fat diet-fed ApoE(-/-) mice. J Ethnopharmacol. 2024;318(Pt A):116916. https://doi.org/10.1016/j.jep.2023.116916.

Article  CAS  PubMed  Google Scholar 

Sharma H, Mossman K, Austin RC. Fatal attractions that trigger inflammation and drive atherosclerotic disease. Eur J Clin Invest. 2024;54(5): e14169. https://doi.org/10.1111/eci.14169.

Article  CAS  PubMed  Google Scholar 

Wong ND, Budoff MJ, Ferdinand K, et al. Atherosclerotic cardiovascular disease risk assessment: an American society for preventive cardiology clinical practice statement. Am J Prev Cardiol. 2022;10: 100335. https://doi.org/10.1016/j.ajpc.2022.100335.

Article  PubMed Central  PubMed  Google Scholar 

Priyamvara A, Dey AK, Bandyopadhyay D, et al. Periodontal inflammation and the risk of cardiovascular disease. Curr Atheroscler Rep. 2020;22(7): 28. https://doi.org/10.1007/s11883-020-00848-6.

Article  PubMed  Google Scholar 

Xu MY, Xu JJ, Kang LJ, et al. Urolithin A promotes atherosclerotic plaque stability by limiting inflammation and hypercholesteremia in Apolipoprotein E-deficient mice. Acta Pharmacol Sin. 2024;45(11):2277–89. https://doi.org/10.1038/s41401-024-01317-5.

Article  CAS  PubMed  Google Scholar 

Liu XR, Xu Q, Xiao J, et al. Role of oral microbiota in atherosclerosis. Clin Chim Acta. 2020;506:191–5. https://doi.org/10.1016/j.cca.2020.03.033.

Article  CAS  PubMed  Google Scholar 

Park S, Kim I, Han SJ, et al. Oral Porphyromonas gingivalis infection affects intestinal microbiota and promotes atherosclerosis. J Clin Periodontol. 2023;50(11):1553–67. https://doi.org/10.1111/jcpe.13864.

Article  CAS  PubMed  Google Scholar 

Pussinen PJ, Kopra E, Pietiäinen M, et al. Periodontitis and cardiometabolic disorders: the role of lipopolysaccharide and endotoxemia. Periodontol 2000. 2022;89(1):19–40. https://doi.org/10.1111/prd.12433.

Article  PubMed Central  PubMed  Google Scholar 

Afzoon S, Amiri MA, Mohebbi M, Hamedani S, Farshidfar N. A systematic review of the impact of Porphyromonas gingivalis on foam cell formation: implications for the role of periodontitis in atherosclerosis. BMC Oral Health. 2023;23(1): 481. https://doi.org/10.1186/s12903-023-03183-9.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Wu Q, Li Z, Zhang Y, et al. Cyclic di-AMP rescues Porphyromonas gingivalis-aggravated atherosclerosis. J Dent Res. 2023;102(7):785–94. https://doi.org/10.1177/00220345231162344.

Article  CAS  PubMed  Google Scholar 

Ge J, Zhu X, Weng C, et al. Periodontitis impacts on thrombotic diseases: from clinical aspect to future therapeutic approaches. Int J Oral Sci. 2024;16(1): 58. https://doi.org/10.1038/s41368-024-00325-9.

Article  PubMed Central  PubMed  Google Scholar 

Xu T, Dong Q, Luo Y, et al. Porphyromonas gingivalis infection promotes mitochondrial dysfunction through Drp1-dependent mitochondrial fission in endothelial cells. Int J Oral Sci. 2021;13(1): 28. https://doi.org/10.1038/s41368-021-00134-4.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Cheng CK, Huang Y. Oral microbiome: a doubtful predictor but potential target of cardiovascular diseases. Med Rev (2021). 2023;3(3):209–13. https://doi.org/10.1515/mr-2023-0015.

Article  PubMed Central  PubMed  Google Scholar 

Jinting Ge XZ, Chengxin Weng D, Yuan J, Zhao L, Zhao. Tiehao Wang and Yafei wu: periodontitis impacts on thrombotic diseases from clinical. Int J Oral Sci. 2024; https://doi.org/10.1038/s41368-024-00325-9

Kebschull M, Demmer RT, Papapanou PN. Gum bug, leave my heart alone!--epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis. J Dent Res. 2010;89(9):879–902. https://doi.org/10.1177/0022034510375281.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Wang ZK, Xu X, Zhou XD. [Latest research findings on the mechanism of periodontal pathogens in cardiovascular disease]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2022;53(4):732–6. https://doi.org/10.12182/20220760108.

Article  PubMed  Google Scholar 

Holden JA, Attard TJ, Laughton KM, Mansell A, O’Brien-Simpson NM, Reynolds EC. Porphyromonas gingivalis lipopolysaccharide weakly activates M1 and M2 polarized mouse macrophages but induces inflammatory cytokines. Infect Immun. 2014;82(10):4190–203. https://doi.org/10.1128/iai.02325-14.

Article  PubMed Central  PubMed  Google Scholar 

Xie M, Tang Q, Nie J, et al. BMAL1-downregulation aggravates Porphyromonas gingivalis-induced atherosclerosis by encouraging oxidative stress. Circ Res. 2020;126(6):e15-29. https://doi.org/10.1161/circresaha.119.315502.

Article  CAS  PubMed  Google Scholar 

Wan H, Lu Y, Yang J, et al. Naoxintong capsule remodels gut microbiota and ameliorates early-stage atherosclerosis in Apolipoprotein E-deficient mice. Phytomedicine. 2024;129: 155662. https://doi.org/10.1016/j.phymed.2024.155662.

Article  CAS  PubMed  Google Scholar 

Tonelli A, Lumngwena EN, Ntusi NAB. The oral microbiome in the pathophysiology of cardiovascular disease. Nat Rev Cardiol. 2023;20(6):386–403. https://doi.org/10.1038/s41569-022-00825-3.

Article  PubMed  Google Scholar 

Huang PE, Shen DN, Wu YF. [Research progress in the interaction between Treponema denticola and microorganisms of subgingival plaque]. Zhonghua Kou Qiang Yi Xue Za Zhi. 2021;56(4):380–4. https://doi.org/10.3760/cma.j.cn112144-20200528-00305.

Article  CAS  PubMed  Google Scholar 

Kwon D, Bae K, Kim H, Kim SH, Lee D, Lee JH. Treponema denticola as a prognostic biomarker for periodontitis in dogs. PLoS One. 2022;17(1): e0262859. https://doi.org/10.1371/journal.pone.0262859.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Jia R, Hashizume-Takizawa T, Du Y, Yamamoto M, Kurita-Ochiai T. Aggregatibacter actinomycetemcomitans induces Th17 cells in atherosclerotic lesions. Pathog Dis. 2015;73(3). https://doi.org/10.1093/femspd/ftu027.

Lund Håheim AL. Oral anaerobe bacteria-a common risk for cardiovascular disease and mortality and some forms of cancer? Front Oral Health. 2024;5: 1348946. https://doi.org/10.3389/froh.2024.1348946.

Article  PubMed Central  PubMed  Google Scholar 

Hashizume-Takizawa T, Yamaguchi Y, Kobayashi R, Shinozaki-Kuwahara N, Saito M, Kurita-Ochiai T. Oral challenge with Streptococcus sanguinis induces aortic inflammation and accelerates atherosclerosis in spontaneously hyperlipidemic mice. Biochem Biophys Res Commun. 2019;520(3):507–13.